Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Erwan Salaun is active.

Publication


Featured researches published by Erwan Salaun.


Chest | 2016

Severe Pulmonary Arterial Hypertension in Patients Treated for Hepatitis C With Sofosbuvir

Sébastien Renard; Patrick Borentain; Erwan Salaun; Sanaa Benhaourech; Baptiste Maille; Albert Darque; Sylvie Bregigeon; Philippe Colson; Delphine Laugier; Martine Reynaud Gaubert; Gilbert Habib

Development of direct-acting antiviral agents against hepatitis C virus (HCV) has changed the management of chronic HCV infection. We report three cases of newly diagnosed or exacerbated pulmonary arterial hypertension (PAH) in patients treated with sofosbuvir. All patients had PAH-associated comorbidities (HIV coinfection in two, portal hypertension in one) and one was already being treated for PAH. At admission, all patients presented with syncope, World Health Organization functional class IV, right-sided heart failure, and extremely severe hemodynamic parameters. After specific PAH therapy, the clinical and hemodynamic properties for all patients were improved. Severity and acuteness of PAH, as well as chronology, could suggest a causal link between HCV treatment and PAH onset. We hypothesize that suppression of HCV replication promotes a decrease in vasodilatory inflammatory mediators leading to worsening of underlying PAH. The current report suggests that sofosbuvir-based therapy may be associated with severe PAH.


Heart | 2017

Risk score for cardiac surgery in active left-sided infective endocarditis

Carmen Olmos; Isidre Vilacosta; Gilbert Habib; Luis Maroto; Cristina Fernández; Javier Lopez; Cristina Sarriá; Erwan Salaun; Salvatore Di Stefano; Manuel Carnero; Sandrine Hubert; Carlos Ferrera; Gabriela Tirado; Afonso Freitas-Ferraz; Carmen Sáez; Javier Cobiella; Juan Bustamante-Munguira; Cristina Sánchez-Enrique; Pablo Elpidio García-Granja; Cécile Lavoute; Benjamin Obadia; David Vivas; Ángela Gutiérrez; José Alberto San Román

Objective To develop and validate a calculator to predict the risk of in-hospital mortality in patients with active infective endocarditis (IE) undergoing cardiac surgery. Methods Thousand two hundred and ninety-nine consecutive patients with IE were prospectively recruited (1996–2014) and retrospectively analysed. Left-sided patients who underwent cardiac surgery (n=671) form our study population and were randomised into development (n=424) and validation (n=247) samples. Variables statistically significant to predict in-mortality were integrated in a multivariable prediction model, the Risk-Endocarditis Score (RISK-E). The predictive performance of the score and four existing surgical scores (European System for Cardiac Operative Risk Evaluation (EuroSCORE) I and II), Prosthesis, Age ≥70, Large Intracardiac Destruction, Staphylococcus, Urgent Surgery, Sex (Female) (PALSUSE), EuroSCORE ≥10) and Society of Thoracic Surgeons’s Infective endocarditis score (STS-IE)) were assessed and compared in our cohort. Finally, an external validation of the RISK-E in a separate population was done. Results Variables included in the final model were age, prosthetic infection, periannular complications, Staphylococcus aureus or fungi infection, acute renal failure, septic shock, cardiogenic shock and thrombocytopaenia. Area under the receiver operating characteristic curve in the validation sample was 0.82 (95% CI 0.75 to 0.88). The accuracy of the other surgical scores when compared with the RISK-E was inferior (p=0.010). Our score also obtained a good predictive performance, area under the curve 0.76 (95% CI 0.64 to 0.88), in the external validation. Conclusions IE-specific factors (microorganisms, periannular complications and sepsis) beside classical variables in heart surgery (age, haemodynamic condition and renal failure) independently predicted perioperative mortality in IE. The RISK-E had better ability to predict surgical mortality in patients with IE when compared with other surgical scores.


European Journal of Echocardiography | 2015

Value of CMR in quantification of paravalvular aortic regurgitation after TAVI.

Erwan Salaun; Alexis Jacquier; Alexis Theron; Roch Giorgi; Marc Lambert; Nicolas Jaussaud; Sandrine Hubert; Frédéric Collart; Jean-Louis Bonnet; Gilbert Habib; Thomas Cuisset; Dominique Grisoli

AIMS To assess the value of cardiac magnetic resonance (CMR) using phase-contrast velocity mapping for paravalvular aortic regurgitation (PAR) quantification. METHODS AND RESULTS All patients undergoing transcatheter aortic valve implantation (TAVI) in our centre between November 2012 and August 2013, without CMR-contraindication were included. PAR severity was assessed 5 days after TAVI using: transthoracic echocardiography (TTE) and CMR [regurgitant volume (RV), regurgitant fraction (RF)]. Aortic regurgitation (AR) index was obtained during TAVI. Thirty of 51 patients who underwent TAVI were included (COREVALVE, n = 10; or EDWARDS SAPIEN XT, n = 20). At TTE, PAR was mild in 22, moderate in 3, and severe in 5 patients. Reliable phase-contrast images were acquired at the sino-tubular junction for SAPIEN and at the tubular portion of the ascending aorta for COREVALVE. The reproducibility of CMR was high (coefficient of correlation = 0.99 for intra- and inter-operator variability). At CMR, RV, and RF were significantly (P < 0.0005) correlated with AR severity at TTE, with mean RF values at 9.2 ± 7.6% in mild, 20.3 ± 4.2% in moderate, and 46.8 ± 10.8% in severe PAR. A cut-off value of RF < 14% at CMR accurately discriminated mild from moderate/severe (sensitivity: 100%, specificity: 82%). The mean AR index was 29.4 ± 6 for mild and 13.8 ± 5 for moderate/severe PAR. Three patients had a RF > 14% and a low AR index <25 despite a mild PAR at TTE, suggesting an underestimation at TTE. CONCLUSION CMR is a reproducible, accurate, and reliable method to assess PAR severity. CMR may allow correcting an underestimation at TTE when AR index is doubtful.


International Journal of Cardiology | 2016

Effect of oversizing and elliptical shape of aortic annulus on transcatheter valve hemodynamics: An in vitro study

Erwan Salaun; Anne-Sophie Zenses; Morgane Evin; Frédéric Collart; Gilbert Habib; Philippe Pibarot; Régis Rieu

BACKGROUND Transcatheter aortic valve implantation (TAVI) is often performed in patients with non-circular aortic annulus and in oversizing (OS) conditions. The impact of elliptical annulus shape and the consequences of oversizing/underdeployment on the hemodynamic performance are still debated. OBJECTIVE This in-vitro study aims to assess and compare the valve hemodynamic performances of the Edwards SAPIEN transcatheter heart valve (THV) in the different current conditions of use: important oversizing in small circular annuli and in elliptical annuli, moderate oversizing in circular and in elliptical annuli of various degrees of eccentricity. METHODS A pulsed cardiovascular simulator was used. Edwards SAPIEN 23 and 26 (mm) were implanted in different circular and elliptical annuli of various sizes and eccentricity. Transvalvular mean pressure gradients (TPGm), effective orifice area (EOA) after implantation of Edwards SAPIEN THV were measured by Doppler-echocardiography and the performance index (PI=100 × EOA/Annulus Area) was calculated. Para and transvalvular regurgitation was assessed by color-Doppler and leakage volume was quantified by flowmeter measurement. RESULTS For a given aortic annulus area, EOAs after implantation of Edwards SAPIEN THV were generally larger and TPGms lower with elliptical annuli compared to circular annuli. The PI was higher (p=0.047) for elliptical (48 ± 3%) than for circular annuli (43 ± 5%). Paravalvular regurgitation occurred only in the case of the SAPIEN 26 implanted in the elliptical annulus with highest eccentricity. CONCLUSION The results of this in-vitro study suggest that the EOAs of Edwards SAPIEN are better in elliptical than in circular annuli. No transvalvular regurgitation occurred and only one paravalvular regurgitation was observed after implantation of SAPIEN 26 in the highly eccentric annulus.


European Journal of Echocardiography | 2018

Patient-prosthesis mismatch in new generation trans-catheter heart valves: a propensity score analysis

Alexis Theron; Johan Pinto; Dominique Grisoli; Karolina Griffiths; Erwan Salaun; Nicolas Jaussaud; Eleonore Ravis; Marc Lambert; Lyna Messous; Cecile Amanatiou; Thomas Cuisset; Vlad Gariboldi; Roch Giorgi; Gilbert Habib; Frédéric Collart

Aims When compared with the former Sapien XT (XT-THV), the Sapien 3 trans-catheter heart valve (S3-THV) embeds an outer annular sealing cuff to prevent para-valvular regurgitation (PVR). The consequences of this new feature on valve haemodynamics have never been evaluated. We aimed to compare both types of prostheses regarding patient-prosthesis mismatch (PPM). Methods and results Patients who underwent a TAVR for aortic stenosis were retrospectively included. Regression adjustment for the propensity score was used to compare 50 XT-THV patients with 71 S3-THV. At the 1-month follow-up, the mean indexed effective orifice area (iEOA) was 1.12 ± 0.34 cm2/m2 with XT-THV and 0.96 ± 0.27 cm2/m2 with S3-THV. The mean gradient was 11 ± 5 mmHg and 13 ± 5 mmHg, respectively. Nine patients had moderate PPM, and two exhibited severe PPM with XT-THV. Nineteen patients had moderate PPM, and seven demonstrated severe PPM with S3-THV. There was a five-fold increased risk of PPM with S3-THV (OR = 4.98; [1.38-20.94], P = 0.019). S3-THV decreased the iEOA by 0.21 cm2/m2 [-0.21; (-0.38 to - 0.05); P = 0.012] and increased the mean gradient by 4.95 mmHg [4.95; (2.27-7.64); P < 0.001]. The risk of PPM was increased 15.24-fold with 23 mm S3-THV [15.24; (2.92-101.52); P = 0.002] in comparison with the 23 mm XT-THV. PVR were reduced by 98% with S3-THV. Conclusion There is an increased risk of PPM with 23mm S3-THV in comparison with 23 mm XT-THV. This may be attributable to the additional sub-annular cuff that avoids the risk of PVR. Regarding the increased vulnerability of younger patients to PPM, we provide essential information on the extension of TAVR indication to the younger population.


Heart | 2017

Infective endocarditis in octogenarians

Léopold Oliver; Cécile Lavoute; Roch Giorgi; Erwan Salaun; Sandrine Hubert; Jean-Paul Casalta; Frédérique Gouriet; Sébastien Renard; Ludivine Saby; Jean-François Avierinos; Laurie-Anne Maysou; Alberto Riberi; Dominique Grisoli; Anne-Claire Casalta; Frédéric Collart; Didier Raoult; Gilbert Habib

Objective To describe the characteristics of infective endocarditis (IE) in octogenarians and assess their prognosis. Methods Patients with definite IE hospitalised at a referral centre between July 2008 and July 2013 were prospectively included. A total of 454 patients were divided into three groups: 230 patients under 65 years old, 173 patients between 65 and 80 years old, and 51 patients over 80 years old. The main end point was 1-year mortality. Results One-year mortality was higher in the ≥80 years old group (37.3%) than in the <65 years old group (13%; p<0.001) and the 65–80 years old group (19.7%; p=0.009). Enterococci and Streptococcus gallolyticus were the more frequent micro-organisms. Embolism under antibiotic therapy (n=11 (21.6%), p=0.03) and renal failure (n=23 (51%), p=0.004) were more frequent in the ≥80 years old group. Among the ≥80 years old group, 38 patients had theoretical indication for surgery. Mortality was low (6.3%) in the 16 operated patients, but very high (72.7%) in the 22 patients not operated. Even if octogenarians were less often operated, their survival after surgery was excellent like younger patients (93.7%, 89.9% and 90.4%, respectively), whereas the absence of surgery was associated with very poor prognosis. Conclusions IE in octogenarians is a different disease, with Enterococci as the most frequent micro-organisms and with higher mortality than younger patients. ESC recommendations for surgery are less implemented than in younger patients, yielding dramatic mortality in patients not operated despite a theoretical indication for surgery, while operated patients have an excellent prognosis. These results suggest that surgery is underused in octogenarians.


European Journal of Echocardiography | 2017

Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document: In collaboration with the 'Working Group on myocardial and pericardial diseases' of the European Society of Cardiology Endorsed by the Indian Academy of Echocardiography.

Gilbert Habib; Chiara Bucciarelli-Ducci; Alida L.P. Caforio; Nuno Cardim; Philippe Charron; Bernard Cosyns; Aure ' Lie Dehaene; Geneviève Derumeaux; Erwan Donal; Marc R. Dweck; Thor Edvardsen; Paola Anna Erba; Laura Ernande; Oliver Gaemperli; Maurizio Galderisi; Julia Grapsa; Alexis Jacquier; Karin Klingel; Patrizio Lancellotti; Danilo Neglia; Alessia Pepe; Pasquale Perrone-Filardi; Steffen E. Petersen; Sven Plein; Bogdan A. Popescu; Patricia Reant; L. Elif Sade; Erwan Salaun; Riemer H. J. A. Slart; Christophe Tribouilloy

Restrictive cardiomyopathies (RCMs) are a diverse group of myocardial diseases with a wide range of aetiologies, including familial, genetic and acquired diseases and ranging from very rare to relatively frequent cardiac disorders. In all these diseases, imaging techniques play a central role. Advanced imaging techniques provide important novel data on the diagnostic and prognostic assessment of RCMs. This EACVI consensus document provides comprehensive information for the appropriateness of all non-invasive imaging techniques for the diagnosis, prognostic evaluation, and management of patients with RCM.


European Journal of Echocardiography | 2016

Cardiac amyloidosis: an unusual cause of low flow–low gradient aortic stenosis with preserved ejection fraction

Fairouz Haloui; Erwan Salaun; Laurie-Anne Maysou; A. Dehaene; Gilbert Habib

Both low flow–low gradient aortic stenosis (LFLG AS) despite preserved ejection fraction (EF) and cardiac amyloidosis (CA) can be observed in elderly patients with left ventricular (LV) hypertrophy, apparently normal LV systolic function but severe longitudinal dysfunction. We report a case of a patient in whom the pattern of LFLG AS was associated with and related …


Archives of Cardiovascular Diseases | 2016

Long-term prognosis of left-sided native-valve Staphylococcus aureus endocarditis.

Layal Abdallah; Jean-Paul Remadi; Gilbert Habib; Erwan Salaun; Jean-Paul Casalta; Christophe Tribouilloy

BACKGROUND Staphylococcus aureus infective endocarditis (SAIE) is a serious and common disease. AIMS To assess the clinical and echocardiographic characteristics and prognostic factors of left-sided native-valve SAIE, and to compare these characteristics between two periods (1990-2000 vs. 2001-2010). METHODS This was a retrospective analysis of 162 cases of left-sided native-valve SAIE among 1254 patients hospitalized for infective endocarditis (IE) between 1990 and 2010. RESULTS SAIE represented 18.1% of all cases of IE and 22.9% of cases of native-valve IE. Complications included heart failure in 44.7% of cases, acute renal failure in 23.3%, sepsis in 28.5%, neurological events in 35.8%, systemic embolic events in 54.9% and in-hospital mortality in 25.3%. Factors associated with in-hospital mortality were heart failure (odds ratio [OR] 2.5; P=0.04) and sepsis (OR 5.3; P=0.001). Long-term 5-year survival was 49.6±4.9%. Factors associated with long-term mortality were heart failure (OR 1.7; P=0.032), sepsis (OR 3; P=0.0001) and delayed surgery (OR 0.43; P=0.003). Comparison of the two periods revealed a significant increase in bivalvular involvement, valvular incompetence and acute renal failure from 2001 to 2010. No significant difference was observed in terms of in-hospital mortality rates (28.1% vs. 23.5%; P=0.58) and long-term 5-year survival (45.0±6.6% vs. 57.1±6.4%; P=0.33). CONCLUSION Mortality as a result of left-sided native-valve SAIE remains high. Factors associated with in-hospital mortality are heart failure and sepsis. Factors associated with long-term mortality are heart failure, sepsis and delayed surgery. Despite progress in surgical techniques, in-hospital mortality and long-term mortality have not decreased significantly between the two periods.


Jacc-cardiovascular Imaging | 2018

Diagnosis of Infective Endocarditis After TAVR: Value of a Multimodality Imaging Approach

Erwan Salaun; Laura Sportouch; Pierre-Antoine Barral; Sandrine Hubert; Cécile Lavoute; Anne-Claire Casalta; Julie Pradier; Daniel Ouk; Jean-Paul Casalta; Marc Lambert; Frédérique Gouriet; Jean-Yves Gaubert; A. Dehaene; Alexis Jacquier; Laetitia Tessonnier; Julie Haentjens; Alexis Theron; Alberto Riberi; Serge Cammilleri; Dominique Grisoli; Nicolas Jaussaud; Frédéric Collart; Jean-Louis Bonnet; Laurence Camoin; Sébastien Renard; Thomas Cuisset; Jean-François Avierinos; Hubert Lepidi; Olivier Mundler; Didier Raoult

Diagnosis of infective endocarditis (IE) after transcatheter aortic valve replacement (TAVR) remains difficult to establish using modified Duke criteria. We present the value of multi-imaging approach (European Society of Cardiology [ESC]-2015 modified criteria) [(1)][1] in 16 patients referred for

Collaboration


Dive into the Erwan Salaun's collaboration.

Top Co-Authors

Avatar

Gilbert Habib

Aix-Marseille University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Thomas Cuisset

Aix-Marseille University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge